Location of Repository

Policy Implications of Genetic Information on Regulation under the Clean Air Act: The Case of Particulate Matter and Asthmatics

By C. Bradley Kramer, Alison C. Cullen and Elaine M. Faustman


The U.S. Clean Air Act (CAA) explicitly guarantees the protection of sensitive human subpopulations from adverse health effects associated with air pollution exposure. Identified subpopulations, such as asthmatics, may carry multiple genetic susceptibilities to disease onset and progression and thus qualify for special protection under the CAA. Scientific advances accelerated as a result of the ground-breaking Human Genome Project enable the quantification of genetic information that underlies such human variability in susceptibility and the cellular mechanisms of disease. In epidemiology and regulatory toxicology, genetic information can more clearly elucidate human susceptibility essential to risk assessment, such as in support of air quality regulation. In an effort to encourage the incorporation of genomic information in regulation, the U.S. Environmental Protection Agency (EPA) has issued an Interim Policy on Genomics. Additional research strategy and policy documents from the National Academy of Science, the U.S. EPA, and the U.S. Department of Health and Human Services further promote the expansion of asthma genetics research for human health risk assessment. Through a review of these government documents, we find opportunities for the inclusion of genetic information in the regulation of air pollutants. In addition, we identify sources of information in recent scientific research on asthma genetics relevant to regulatory standard setting. We conclude with recommendations on how to integrate these approaches for the improvement of regulatory health science and the prerequisites for inclusion of genetic information in decision making

Topics: Commentaries & Reviews
Publisher: National Institute of Environmental Health Sciences
OAI identifier: oai:pubmedcentral.nih.gov:1392222
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2002). A comprehensive review of genetic association studies.
    2. (1996). A genome-wide search for quantitative trait loci underlying asthma.
    3. (2002). A major susceptibility gene for asthma maps to chromosome 14q24.
    4. (2003). A new gene for asthma: would you ADAM and Eve it?
    5. (2000). Action against Asthma.
    6. (2003). ADAM 33: just another asthma gene or a breakthrough in understanding the origins of bronchial hyperresponsiveness?
    7. (2004). Air Quality Criteria for Particulate Matter.
    8. (1993). An association between air pollution and mortality in six U.S. cities.
    9. (2003). Association between an interleukin-13 promoter polymorphism and atopy.
    10. (2003). Association of a disintegrin and metalloprotease 33 (ADAM 33) gene with asthma in ethnically diverse populations.
    11. (2002). Asthma genetics. Chest 121(suppl 3):7S–13S.
    12. (2004). Asthma Genomics: Implications for Public Health. Seattle, WA:University of Washington.
    13. (2005). Asthma Prevalence, Health Care Use and Mortality,
    14. (2002). Asthma Toxics Research Strategy.
    15. (1997). Biomarkers: coming of age for environmental health and risk assessment.
    16. (1990). Clean Air Act Amendments of
    17. (1997). Collaborative Study on the Genetics of Asthma.
    18. (2001). Current concepts on the genetics of asthma.
    19. (2004). Draft Potential Implications for Genomics for Regulatory and Risk Assessment Applications at EPA.
    20. (1997). Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma.
    21. (2003). Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma—Update on Selected Topics
    22. (2002). Gene-gene interaction in asthma: IL-4RA and IL-13 in a Dutch population with asthma.
    23. (2002). Genetic and perinatal risk factors for asthma onset and severity: a review and theoretical analysis.
    24. (2003). Genetic polymorphism in allergy and asthma.
    25. (1999). Genetics of allergy and asthma.
    26. (2000). Genetics of asthma and allergies.
    27. (2001). Genomewide screen and identification of genegene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma.
    28. (2003). Genomic priorities and public health.
    29. (2002). Hazardous air pollutants and asthma.
    30. (2001). Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population.
    31. (2002). Interactions between genes and environmental factors in asthma and atopy: new developments.
    32. (1999). Looking at environmental justice from an environmental health perspective.
    33. (2000). Medicine, Committee on the Assessment of Asthma and Indoor Air.
    34. (2004). NRC Committee on Research Priorities for Airborne Particulate Matter.
    35. (1980). of Appeals, District of Columbia Circuit,
    36. (2000). Online Mendelian Inheritance in Man (OMIM).
    37. (2002). Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations.
    38. (1995). Particulate air pollution as a predictor of mortality in a prospective study of US adults.
    39. (2000). Polymorphisms of the IL-4, TNF-alpha, and Fc epsilon RI-beta genes and the risk of allergic disorders in at-risk infants.
    40. (2002). Relation between tumour necrosis factor polymorphism TNFα-308 and risk of asthma.
    41. (2001). Replication validity of genetic association studies.
    42. (1994). Research Council) Committee on Risk Assessment and Hazardous Air Pollutants.
    43. (1995). Research to strengthen the scientific basis for health risk assessment: a survey of the context and rationale for mechanistically based methods and models.
    44. (2003). Review of the National Ambient Air Quality Standards for Particulate Matter: Policy Assessment
    45. (1999). The alliance of genes and environment in asthma and allergy. Nature 402(suppl 6760):B5–B11.
    46. (2001). The health economics of asthma and rhinitis. I. Assessing the economic impact.
    47. (2002). Toxicogenomics and toxic torts.
    48. (2000). Toxicological bases for the setting of health-related air pollution standards. Annu Rev Public Health 21:309–333.
    49. (2002). Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop. Environ Health Perspect 110:1047–1050.
    50. (2000). What constitutes an adverse health effect of air pollution?
    51. (2003). Workshop overview: use of genomic data in risk assessment.
    52. (2004). β2-Adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.